Biologic MateR clinical performance test for ADA and TCZ Efficacy predictio
Not Applicable
- Conditions
- rheumatoid arthritis
- Registration Number
- JPRN-UMIN000015616
- Lead Sponsor
- Biologic Mate Study Group
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 300
Inclusion Criteria
Not provided
Exclusion Criteria
Be against the guideline of ADA,TCZ and MTX Patient is otherwise ineligible to participate in this study in the investigator's opinion
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method ADAMTS5mRNA dose at 0wk. Remission rate and ACR response at 24wk.
- Secondary Outcome Measures
Name Time Method SDAI CDAI and Boolean rates at 24wk.